a strong trendp = 0.06
Although total ICAM-1 levels showed no significant change in response to either Aβ40 or Aβ42 treatment, biotinylation assays revealed significantly increased cell surface ICAM-1 levels, but not VCAM-1 levels, in response to 0.1 μM of Aβ40 ( p = 0.009) and a strong trend in response to Aβ42 ( p = 0.06) (Additional file 6 h–j).